enGene Holdings Inc.

enGene Holdings Inc.verified

ENGN

Price:

$1.62

Market Cap:

$82.94M

Operating through its subsidiary, enGene, Inc., enGene Holdings Inc. functions as a clinical-stage biotechnology firm. Its core mission involves pioneering genetic pharmaceuticals, achieved by administering therapeutic agents directly to mucosal tissues and other bodily organs. A key asset in its pipeline is EG-70, also known as detalimogene voraplasmid. This innovative non-viral immunotherapy is being developed to treat non-muscle invasive bladder cancer in patients diagnosed with carcinoma-in-situ (Cis) who have shown no improvement after Bacillus Calmette-Guérin therapy. The company was established in 2023 and is headquartered in Saint-Laurent, Canada.

Industry

Biotechnology

IPO Date

2022-02-01

Stock Exchange

NASDAQ

Ticker

ENGN

The Enterprise Value as of June 2026 (TTM) for enGene Holdings Inc. (ENGN) is 79.79M

According to enGene Holdings Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 79.79M. This represents a change of -76.55% compared to the average of 340.22M of the last 4 quarters.

enGene Holdings Inc. (ENGN) Historical Enterprise Value (quarterly & annually)

How has ENGN Enterprise Value performed in the past?

The mean historical Enterprise Value of enGene Holdings Inc. over the last ten years is 271.30M. The current 79.79M Enterprise Value has changed 2.84% with respect to the historical average. Over the past ten years (40 quarters), ENGN's Enterprise Value was at its highest in in the January 2026 quarter at 637.87M. The Enterprise Value was at its lowest in in the January 2024 quarter at 120.75M.

Quarterly (TTM)
Annual

Average

271.30M

Median

315.57M

Minimum

0

Maximum

399.40M

enGene Holdings Inc. (ENGN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of enGene Holdings Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = Infinity%

Maximum Annual Enterprise Value = 399.40M

Minimum Annual Increase = -38.14%

Minimum Annual Enterprise Value = 0

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025350.21M41.75%
2024247.06M-38.14%
2023399.40M26.41%
2022315.95M0.24%
2021315.19MInfinity%

enGene Holdings Inc. (ENGN) Average Enterprise Value

How has ENGN Enterprise Value performed in the past?

The current Enterprise Value of enGene Holdings Inc. (ENGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

332.23M

5-year avg

325.56M

10-year avg

271.30M

enGene Holdings Inc. (ENGN) Enterprise Value vs. Peers

How is ENGN’s Enterprise Value compared to its peers?

enGene Holdings Inc.’s Enterprise Value is less than Amarin Corporation plc (189.73M), less than Altimmune, Inc. (168.60M), less than Korro Bio, Inc. (96.75M), less than DBV Technologies S.A. (366.68M), less than Larimar Therapeutics, Inc. (122.82M), less than Cellectis S.A. (304.86M), less than Annexon, Inc. (413.52M), less than Alto Neuroscience, Inc. (495.40M), less than AC Immune S.A. (172.37M), less than Silence Therapeutics plc (310.47M),

CompanyEnterprise ValueMarket cap
189.73M$315.21M
168.60M$230.35M
96.75M$115.56M
366.68M$416.60M
122.82M$296.96M
304.86M$310.29M
413.52M$563.29M
495.40M$753.47M
172.37M$235.10M
310.47M$316.00M

Build a custom stock screener for enGene Holdings Inc. (ENGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like enGene Holdings Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

enGene Holdings Inc. (ENGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like enGene Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is enGene Holdings Inc.'s Enterprise Value?

What is the highest Enterprise Value for enGene Holdings Inc. (ENGN)?

What is the 3-year average Enterprise Value for enGene Holdings Inc. (ENGN)?

What is the 5-year average Enterprise Value for enGene Holdings Inc. (ENGN)?

How does the current Enterprise Value for enGene Holdings Inc. (ENGN) compare to its historical average?